Fig. 12From: Advances in blood–brain barrier-crossing nanomedicine for anti-gliomaAdapted from Ref. (Marino et al. 2019) with permission from The Royal Society of Chemistry copyright 2019; adapted from ref. (Afzalipour et al. 2021) with permission from Elsevier Inc. copyright 2020Chemotherapy combined with magnetic hyperthermia therapy. a The structure and characterization of lipid magnetic nanovectors (LMNVs) (Marino et al. 2019). b Characterization of TMZ/MNPs-FA nanoparticles (Afzalipour et al. 2021).Back to article page